Skip to main content

Annals of Hematology

Ausgabe 11/2024

Inhalt (57 Artikel)

Recent advancements in biomarkers, therapeutics, and associated challenges in acute myeloid leukemia

  • Review

Suresh Kumar Prajapati, Neha Kumari, Doulat Bhowmik, Reeshu Gupta

Recent advances in CD5+ diffuse large B-cell lymphoma

  • Review

Ningning Yue, Qiqi Jin, Cuicui Li, Litian Zhang, Jiajia Cao, Chongyang Wu

Prognostic significance of CRLF2 in patients with acute lymphoblastic leukemia: a meta-analysis and systematic review

  • Review

Zilu Meng, Hanxue Zheng, Yang Liu, Xiaojia Guo, Songlin Chu, Wen Zhou, Yanhong Li, Jun Bai, Liansheng Zhang, Lijuan Li

Role of allogeneic hematopoietic cell transplantation in VEXAS syndrome

  • Open Access
  • Review

Ajoy L. Dias, Emma M. Groarke, Dennis Hickstein, Bhavisha Patel

Trans-acting genetic modifiers of clinical severity in heterozygous β-Thalassemia trait

  • Review

Joanna B. Loh, Jules M. Ross, Khaled M. Musallam, Kevin H. M. Kuo

Initial US tertiary health care system experience using caplacizumab in patients with immune thrombotic thrombocytopenic purpura

  • Research

Jennifer M. Jones, Alesia Kaplan, Irina Chibisov, Janine Then, Enrico M. Novelli, Joseph E. Kiss

Manifestations and outcomes of digestive tract involvement in adult Langerhans cell histiocytosis

  • Research

Qing Shang, Long Chang, Min Lang, Zheng-zheng Liu, He Lin, Jin-hua Zhao, Yue Li, Xin-xin Cao

Rosai-Dorfman-Destombes disease in adults: a single center experience

  • Research

Emily Leung, Collin Pryma, Stephen Murphy, Rebecca Harrison, Erica Peterson, Peter W. K. Tsang, Julia Varghese, Xiaotian (Julie) You, Graham W. Slack, Brian F. Skinnider, Tony Ng, Sean Young, Steven Burrell, Ryan Stubbins, Howard Lim, Mollie Carruthers, Jan Dutz, Eli L. Diamond, Luke Y. C. Chen

Distinct mutation features and its clinical significance in myelodysplastic syndromes with normal karyotype

  • Research

Nanfang Huang, Chunkang Chang, Lingyun Wu, Qi He, Zheng Zhang, Xiao Li, Feng Xu

Increased trough concentration of venetoclax when combined with itraconazole for acute myeloid leukemia

  • Research

Masao Hagihara, Takeo Yasu, Yoshito Gando, Tomiyuki Sugi, Shiori Nakashima, Yui Imai, Hirofumi Nakano, Tomoyuki Uchida, Morihiro Inoue

Investigation of infections status in pediatric patients with acute myeloid leukemia during the induction period–a retrospective study in two medical centers

  • Research

Qingyuan Xu, Hongqiao Li, Pengli Huang, Wei Lin, Peijing Qi, Linya wang, Ying Wu, Jia Fan, Bei Hou, Mengjia Liu, Jie Yang, Huiqing Liu, Jiaole Yu, Yuanyuan Zhang, Yu Lu, Qian Huang, Yan Liu, Huyong Zheng

Only FLT3-ITD co-mutation did not have a deleterious effect on acute myeloid leukemia patients with NPM1 mutation, but concomitant with DNMT3A co-mutation or a < 3log reduction of MRD2 predicted poor survival

  • Research

Wenbing Duan, Jinsong Jia, Jing Wang, Xiaohong Liu, Wenjing Yu, Xiaolu Zhu, Ting Zhao, Qian Jiang, Guorui Ruan, Xiaosu Zhao, Hongxia Shi, Yingjun Chang, Yu Wang, Lanping Xu, Xiaohui Zhang, Xiaojun Huang, Hao Jiang

Outcomes of chronic myeloid leukemia patients after therapeutic failure to conventional tyrosine kinase inhibitors and asciminib

  • Open Access
  • Research

Lucía Pérez-Lamas, Adrián Segura Díaz, Elvira Mora Casterá, Marta Hidalgo Soto, Antonio Paz Coll, Natalia De las Heras, Montse Cortes, Patricia Vélez Tenza, Magdalena Sierra Pacho, Alicia Senin Magan, Anna Angona, Carlos Cervero, Raquel de Paz, Araceli Salamanca Cuenca, Marta Santaliestra, Javier López Marín, Luis Felipe Casado, Valentín García-Gutiérrez

Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio as novel prognostic biomarkers in BCR-ABL negative myeloproliferative neoplasms

  • Research

Mirjana Cvetković, Isidora Arsenović, Mihailo Smiljanić, Marta Sobas, Andrija Bogdanović, Danijela Leković

A phase Ib trial of isatuximab, bendamustine, and prednisone in relapsed/refractory multiple myeloma

  • Research

Scott R. Goldsmith, Michael J. Slade, Mark Fiala, Melinda Harding, Zachary D. Crees, Mark A. Schroeder, Keith Stockerl-Goldstein, Ravi Vij

Treatment patterns and burden of infection in patients with chronic lymphocytic leukemia and secondary immunodeficiency: a retrospective database study

  • Open Access
  • Research

Csaba Siffel, Joshua Richter, Colin Anderson-Smits, Marta Kamieniak, Kaili Ren, Drishti Shah, Matthew S. Davids

An inherited genetic variant of the CEP72 gene is associated with the development of vincristine-induced peripheral neuropathy in female patients with aggressive B-cell lymphoma

  • Open Access
  • Research

Konstantinos Christofyllakis, Dominic Kaddu-Mulindwa, Vadim Lesan, Torben Rixecker, Igor Age Kos, Gerhard Held, Evi Regitz, Michael Pfreundschuh, Joerg Thomas Bittenbring, Lorenz Thurner, Viola Poeschel, Marita Ziepert, Bettina Altmann, Moritz Bewarder

Safety of Rituximab biosimilar (Riximyo®) following a single switch from the reference product in patients with Non-Hodgkin’s lymphoma: a retrospective study

  • Open Access
  • Research

Nina K Song, Hala Musa, Michael Soriano, David E Hibbs, Iqbal Ramzan, Jennifer A Ong

Lymphocyte recovery after bendamustine therapy in patients with mantle cell lymphoma. Results of a retrospective analysis and prognostic impact in the CAR-T era

  • Research

Livia Donzelli, M. Antonacci, N. Zhdanovskaya, L. Petrucci, M. Di Palma, M. Martelli, A. Di Rocco

Olverembatinib treatment in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

  • Research

Yiyan Zhu, Jiayi Huang, Ying Wang, Yue Han, Shengli Xue, Yonggong Yang, Yu Zhu, Wenzhi Cai, Suning Chen

Clinical characteristics and prognosis of patients with newly diagnosed primary central nervous system lymphoma: a multicentre retrospective analysis

  • Research

Si-Jun Bai, Jian-Xia He, Yuan-Jun Zheng, Ye Geng, Yi-Nan Gao, Cai-Xia Zhang, Ya-Ru Wang, Li-Yuan Qin, Wen-Jun Wang, Lin-Hua Yang

Early prediction of platelet recovery with immature platelet fraction in patients receiving hematopoietic stem cell transplantation

  • Open Access
  • Research

Tsung-Han Yang, Chun-Kuang Tsai, Hao-Yuan Wang, Po-Shen Ko, Sheng-Hsuan Chien, Ting-An Lin, Wen-Chun Chen, Te-Lin Hsu, Chiu-Mei Yeh, Ching-I Lu, Wan-Jou Lin, Ying-Ju Chen, Chia-Jen Liu, Chun-Yu Liu

Measurable residual disease assessment prior to allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia and myelodysplastic syndromes: a 20-year monocentric study

  • Research

Alexandre-Raphael Wery, Adriano Salaroli, Fabio Andreozzi, Marianne Paesmans, Laurent Dewispelaere, Pierre Heimann, Sebastian Wittnebel, Philippe Lewalle

Interventional antibiotic treatment replacing antibiotic prophylaxis during allogeneic hematopoietic stem cell transplantation is safe and leads to a reduction of antibiotic administration

  • Research

Rosa Toenges, Fabian Lang, Rakhshinda Ghaffar, Sarah Lindner, Vera Schlipfenbacher, Julia Riemann, Salem Ajib, Khouloud Kouidri, Anjali Cremer, Bodo Weber, Ngoc Thien Thu Nguyen, Antje Knoch, Janne Vehreschild, Hubert Serve, Gesine Bug

Early autologous and/or allogeneic stem cell transplantation for adult patients with advanced stage T- lymphoblastic leukemia/lymphoma or Burkitt lymphoma. A retrospective single-centre analysis

  • Open Access
  • Research

N. Steiner, K. Baier, D. Ritter, J. Rudzki, G. Hetzenauer, S. Köck, B. Kircher, E. Gunsilius, D. Wolf, D. Nachbaur

Addition of ruxolitinib and decitabine to modified busulfan/cyclophosphamide conditioning regimen for prophylaxis relapse in high-risk acute myeloid leukemia: the phase 2 prospective study

  • Research

Yujun Wei, Kun Qian, Ning Le, Lili Wang, Fei Li, Songhua Luan, Lu Wang, Xiangshu Jin, Bo Peng, Nan Wang, Liping Dou, Daihong Liu

Baseline platelet count and long-term clinical outcomes in patients with acute venous thromboembolism: a prospective cohort study

  • Open Access
  • Research

Johann Stuby, Odile Stalder, Andreas Limacher, Marc Righini, Nicolas Rodondi, Tobias Tritschler, Marie Méan, Drahomir Aujesky

Secondary prophylaxis of venous thromboembolism (VTE) with low dose apixaban or rivaroxaban in major-thrombophilia carriers

  • Research

Alessandro Laganà, Silvia Sorella, Ludovica Fucci, Cristina Santoro, Silvio Ligia, Rosaria Mormile, Erminia Baldacci, Antonio Chistolini

Impact of clinically unsuspected venous thrombotic events on CVC removal and survival in pediatric cancer patients: A population-based study from the Maritimes, Canada

  • Research

Emma E. MacDonald, Zara N. Forbrigger, Brett Ells, Tamara MacDonald, Neil A. Goldenberg, Ketan Kulkarni

Assessment of the clinical and laboratory risk factors for thrombosis in neonates admitted to neonatal intensive care unit (two Egyptian tertiary centers experience)

  • Open Access
  • Research

Ebtihal Mokhtar Abdelsamei, Gehan Lotfy Abdel Hakeem, Nadia Mohamed El Amin, Maha Ahmed Yousef, Hager Samy Ghalioub, Zamzam Hassan Mohamed

Long-term complete remission in a patient with high-risk primary mediastinal B-cell lymphoma and iatrogenic symptomatic bradycardia after only two courses of DA-EPOCH-R followed by chemo-free treatment

  • Case Report

Francesco Volzone, Cristina Becchimanzi, Stefania Crisci, Annarosaria De Chiara, Annamaria Porto, Antonietta Caronna, Annarosa Cuccaro, Sabrina Sarno, Domenico Mallardo, Lucio Cagini, Rosaria De Filippi, Antonio Pinto

Varying concentrations of tyrosine kinase inhibitors in chronic myeloid leukemia patients following bariatric surgery: a case series

  • Open Access
  • Case Report

Cedric Lau, Charlotte van Kesteren, Yong Xin Cao, Robert M. Smeenk, Laura G.M. Daenen, Jeroen J.W.M. Janssen, Peter E. Westerweel

Vaginal involvement as a rare extranodal manifestation in advanced-stage follicular lymphoma: a case report and literature review

  • Case Report

Hongyun Chen, Junling Zhuang, Wei Zhang, Daobin Zhou, Xiaoyu Wang, Congwei Jia, Danqing Zhao

A rare case of glanzmann thrombasthenia with concomitant factor VII deficiency

  • Case Report

Muhammad Zohair, Ahsan Qayoom, Muhammad Luqman, Muzammil Ahmed, Muhammad Talha Khan

Allogeneic amnion transplantation for the management of cutaneous graft-versus-host disease with associated ulcers: A promising therapeutic strategy

  • Open Access
  • Case Report

Andreas Siegmund, Daniel Wolff, Andrea Pagani, Marc Ruewe, Silvan Klein, Wolfgang Herr, Lukas Prantl, Sebastian Geis

Approaches for the diagnosis and treatment of VEXAS syndrome: the importance of clinical suspicion and the use of methotrexate

  • Case Report

Maria De Santis, Antonio Tonutti, Francesca Motta, Gabriele Todisco, Nicla Manes, Chiara Milanesi, Rossella Caselli, Serena Albertazzi, Arturo Bonometti, Carlo Selmi, Matteo Giovanni Della Porta

Unravelling a KMT2A::ARHGEF12 fusion within chromoanagenesis in acute myeloid leukemia using Optical Genome Mapping

  • Open Access
  • Case Report

Corentine Klos, Pauline Roynard, Céline Berthon, Valérie Soenen, Alice Marceau, Elise Fournier, Laurene Fenwarth, Agnès Daudignon, Catherine Roche, Hélène Guermouche

Aspergillus calidoustus and Talaromyces columbinus infections in chronic graft-versus-host disease

  • Open Access
  • Case Report

Emanuele Pacini, Silke Schelenz, Alireza Abdolrasouli, Varun Mehra, M. Mansour Ceesay, Antonio Pagliuca, Daniele Avenoso

15-year remission in refractory FLT3-mutated AML attained by sorafenib

  • Open Access
  • Case Report

Christoph Rummelt, Dietmar Pfeifer, Ralph Wäsch, Robert Zeiser, Justus Duyster, Jürgen Finke, Michael Lübbert

Alectinib maintenance therapy following cord blood transplantation for relapsed pediatric anaplastic large cell lymphoma with central nervous system involvement

  • Case Report

Kosuke Tamefusa, Hisashi Ishida, Daisuke Miyahara, Takahiro Shiwaku, Motoharu Ochi, Kiichiro Kanamitsu, Kaori Fujiwara, Yasuhisa Tatebe, Kana Washio, Tomoyuki Akiyama, Hirokazu Tsukahara

CAR-T cells for the treatment of pediatric chronic myeloid leukemia in repeatedly relapsed lymphoid blast phase

  • Open Access
  • Case Report

Laura-Jane Kramp, Christiane Heydrich-Karsten, Stephanie Sembill, Axel Karow, Thomas Lion, Guranda Chitadze, Meinolf Suttorp, Gunnar Cario, Markus Metzler

Successful ruxolitinib rechallenge after fedratinib failure in a patient with overt myelofibrosis

  • Correspondence

László Imre Pinczés, Ádám Jóna, Gabriella Mezei, Anna Kenyeres, Péter Pambó Vekszler, Árpád Illés, Zsófia Simon

Fatal heart tamponade during induction treatment with azacitidine and venetoclax

  • Correspondence

Ivan Krecak, Marijana Supe, Bernarda Markov, Marko Skelin, Marko Lucijanic

Minimal residual disease monitoring by Ig/TCR gene rearrangements predicts post-transplant relapse and survival in adult patients with acute lymphoblastic leukemia

  • Open Access
  • Letter to the Editor

Michael Stephan Bader, Susanne Kubetzko, Beat Werner Schäfer, Christian Arranto, Beatrice Drexler, Jörg Halter, Jakob R. Passweg, Michael Medinger

Correction to: Daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible Asian patients with newly diagnosed multiple myeloma: final analysis of the phase 3 OCTANS study

  • Open Access
  • Correction

Weijun Fu, Soo-Mee Bang, Honghui Huang, Kihyun Kim, Wei Li, Gang An, Je-Jung Lee, Zhen Cai, Jie Jin, Yafei Wang, Chor Sang Chim, Robin Carson, Rui Liu, Man Zhao, Xi Chen, Canchan Cui, Jian Hou, Jianxiang Wang

Correction to: Comorbidities and survival of multiple myeloma patients diagnosed in Finland between 2000 and 2021

  • Open Access
  • Correction

Kai Kysenius, Anna Anttalainen, Iiro Toppila, Tatu Miettinen, Mariann Lassenius, Juha Lievonen, Anu Partanen, Raija Silvennoinen, Mervi Putkonen

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

NRG1-Fusionen als neues, klinisch relevantes Target

Ergebnisse einer Phase-II-Studie deuten darauf hin, dass ein gegen HER3 und HER2 gerichteter Antikörper bei verschiedenen NRG1-Fusions-positiven Tumoren wirksam sein könnte. In den USA ist die Substanz bereits beschleunigt zugelassen worden.

Die aktuelle S3-Leitlinie zu CLL strotzt vor Neuerungen

Vor kurzem wurde eine neue, grundlegend überarbeite Version der S3-Leitlinie Chronische Lymphatische Leukämie (CLL) veröffentlicht.  Zu den wichtigsten Änderungen gehört, dass die Chemoimmuntherapie auf dem Rückzug ist.

Obinutuzumab verbessert Therapie der Lupus-Nephritis

In einer internationalen Studie führte die zusätzliche Gabe von Obinutuzumab zur Standardtherapie bei fast der Hälfte der Patientinnen und Patienten mit Lupus-Nephritis zu einem vollständigen Ansprechen der Nieren und war damit wirksamer als die Standardtherapie allein.

Appendizitis und Darminfarkt durch Blinddarm-Lipom

Eigentlich sind Lipome recht harmlos. Im Zäkum können sie jedoch erhebliche Komplikationen mit Darminfarkt und Appendizitis verursachen.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.